0

Certificate of analysis

Certificate of analysis (COA) is the per-batch documentation package that records the analytical-testing results for a specific manufactured batch of a research compound. The credible COA pairs HPLC purity quantitation with mass spectrometric identity confirmation on the same batch and includes the raw analytical data so the buyer can verify the vendor’s claims directly.

Definition

A certificate of analysis is the per-batch documentation issued by the manufacturer (or the contract testing laboratory) that records analytical-testing results for a specific manufactured batch. The certificate identifies the compound, the batch (typically by a lot number or batch identifier), the test methods applied, the specifications against which the batch was evaluated, the results obtained, and a statement of whether the batch passes the established specifications. For a research-peptide supply specifically, the canonical COA contents include the HPLC chromatogram with calculated purity percentage, the mass spectrum with theoretical-vs-observed mass comparison, the appearance and physical description of the lyophilised material, and any additional tests applicable to the specific compound (water content by Karl Fischer, peptide content by quantitative amino-acid analysis, residual solvents, etc.).

The structural distinction between a credible and a non-credible COA is the inclusion of raw analytical data. A certificate that lists only a headline purity percentage without the underlying chromatogram and mass spectrum is not externally verifiable — the buyer has no way to confirm the methods were appropriate, the integration was correct, or the identity check was actually performed. The credible COA reproduces the analytical traces themselves so an independent reviewer can verify the data.

How COA testing is structured in research-peptide supply

For research-peptide supply, COA testing is most credibly performed by an independent third-party analytical laboratory rather than by the manufacturer in-house. The third-party arrangement separates the testing function from the production function, removes the conflict of interest that would exist if the manufacturer self-certified their own purity claims, and provides an external chain-of-custody record for the analytical results. Industry-standard third-party testing for research peptides includes HPLC purity by reversed-phase HPLC at peptide-bond wavelengths, mass spectrometric identity by ESI-MS or MALDI-MS, and appearance / physical-description verification.

The analytical-validation framework for COA test methods is set out in ICH Q2(R1) and the corresponding USP general chapters. Per-compound impurity-threshold considerations are in USP <1086> Impurities in Drug Substances and Drug Products. For Ronin specifically, every supplied batch is third-party tested before release and the per-batch COA is available via the email-gating workflow on the lab results page.

Related terms

Where COAs appear in the Ronin workflow

Every Ronin batch ships with a third-party COA covering HPLC purity and mass spectrometric identity. The COA is available via the email-gating workflow on the lab results page. The Quality verification block on each product page summarises the testing chain.

References

  1. ICH Q2(R1) — Validation of Analytical Procedures: Text and Methodology. International Council for Harmonisation guideline.
  2. USP <1086> Impurities in Drug Substances and Drug Products — framework for impurity identification, qualification, and reporting on certificates of analysis.
  3. USP <621> Chromatography — general chapter defining system suitability and reporting for chromatographic methods reported on COAs.

Glossary entries describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Every compound in the Ronin catalog is sold strictly for laboratory and research use only.

Shopping Cart
Scroll to Top